Compare GSBD & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GSBD | SDGR |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | United States |
| Employees | N/A | 850 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 854.2M |
| IPO Year | 2013 | 2020 |
| Metric | GSBD | SDGR |
|---|---|---|
| Price | $9.23 | $11.39 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $9.00 | ★ $21.13 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 14.32% | N/A |
| EPS Growth | ★ 87.27 | 45.14 |
| EPS | ★ 1.03 | N/A |
| Revenue | N/A | ★ $255,869,000.00 |
| Revenue This Year | N/A | $1.20 |
| Revenue Next Year | N/A | $4.36 |
| P/E Ratio | $8.91 | ★ N/A |
| Revenue Growth | N/A | ★ 23.29 |
| 52 Week Low | $8.81 | $11.11 |
| 52 Week High | $12.38 | $27.63 |
| Indicator | GSBD | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 36.15 |
| Support Level | $8.94 | $11.11 |
| Resistance Level | $9.53 | $13.36 |
| Average True Range (ATR) | 0.19 | 0.54 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 49.37 | 1.68 |
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.